Michael Okunewitch

Stock Analyst at Maxim Group

(0)
# 4787
Out of 5,386 analysts
28
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
HCWB HCW Biologics
Maintains: Buy
120 35
4.54 670.93% 2 May 29, 2025
CTOR Citius Oncology
Downgrades: Hold
n/a
n/a n/a 2 May 23, 2025
ANEB Anebulo Pharmaceutic...
Maintains: Buy
6 3
1.32 127.27% 2 May 15, 2025
RADX Radiopharm Theranost...
Initiates Coverage On: Buy
12
4.64 158.62% 1 May 1, 2025
CMMB Chemomab Therapeutic...
Maintains: Strong Buy
4 7
1.17 498.29% 2 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
1.4 900% 1 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
0.99 203.03% 1 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
1.01 296.04% 1 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
0.65 1746.15% 1 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 6
1.34 347.76% 2 Aug 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 12
0.84 1328.57% 2 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2
n/a n/a 1 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
1.21 1883.47% 1 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
108 18
2.95 510.17% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2025
n/a n/a 1 Apr 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
19.22 30.07% 1 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.63 268.1% 1 Sep 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Feb 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
2.19 1041.55% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
1.53 6435.95% 1 Nov 30, 2021